Willingness and acceptability of cervical cancer screening among women living with HIV/AIDS in Addis Ababa, Ethiopia: a cross sectional study by unknown
RESEARCH Open Access
Willingness and acceptability of cervical cancer
screening among women living with HIV/AIDS in
Addis Ababa, Ethiopia: a cross sectional study
Netsanet Belete1, Yosief Tsige2 and Habtamu Mellie3*
Abstract
Background: In Ethiopia, cervical cancer (CC) ranks the 2nd most frequent cancer and the country had 27.19
million women at risk of developing the disease though only 0.6 % women age 18-69 years was screened every
3 years. Nearly a quarter (22.1 %) of southern Ethiopia HIV (Human Immunodeficiency Virus) infected Women were
positive for precancerous cervical cancer. Doing regular screening can prevent the disease by around half (45 %) of
the cases in age of 30s and three quarter (75 %) cases in 50s and 60s.In the presence of high risk for acquiring
cervical cancer among HIV patients, willingness and acceptance of the screening is low in Addis Ababa, Ethiopia
thus the current study was aimed to assess willingness and acceptability of cervical cancer screening and its
determinants among women living with HIV/AIDS in Addis Ababa, Ethiopia.
Method: A facility based cross sectional study was conducted among HIV positive women attending HIV treatment
centers in Addis Ababa. The respondents were identified using systematic random sampling method. Data was
collected using pretested questionnaire and were entered in to Epi-info version 3.5.1 software and exported in to
SPSS version 20 statistical package for analysis. The criterias for entering independent variables into multivariate
analysis were having p-value 0.05 or less at bivariate analysis and not co-linear.
Result: One third (34.2 %) of participants knew cervical cancer and two third (62.7 %) were willing for the test
though only a quarter (24.8 %) were accepted the test. The independent variables significantly associated with
acceptance of screening were educational level, source of information, awareness for the test and preventability of
the disease.
Conclusion: In current study willingness and acceptance of CC (cervical cancer) were low thus organizations
working on cancer and HIV/AIDS should establish cervical cancer screening program and further enhance
awareness creation.
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Background
In women, cervical cancer is the fourth most common
cancer accounting about 20.4 % of all cancers globally,
with an estimated 528,000 new cases in 2012 [1, 2].
Majority (85 %) of the global burden occurs in the less
developed regions, where it accounts for almost 12 %
of all female cancers. In sub-Saharan Africa, 34.8 new
cases of cervical cancer are diagnosed per 100, 000
women annually and it happens in about 60 % women
living with HIV infection [3–5].
There were an estimated 266,000 global deaths from
cervical cancer in 2012, accounting for 7.5 % of all fe-
male cancer deaths. Almost nine out of ten (87 %) CC
deaths occur in less developed regions. In sub-Saharan
Africa, the mortality is 22.5 per 100,000 though it is less
than 2 per 100,000 in Western Asia, Western Europe
and Australia/New Zealand [1, 2].
In 2014, the expected diagnosis and death from inva-
sive cervical cancer in America was 12,360 and 4,020
respectively [6].
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More than one fifth of all new cervical cancer cases
globally are diagnosed in India. In the country, the dis-
ease ranked 2nd cause of female cancer. According to
2012 estimate, the country annual diagnosed cases and
deaths from the disease was 122,844 and 67,477 respect-
ively [2, 7]. In Taiwan the incidence rate of the disease
among HIV infected women was 712.08/100,000 person-
years [8].
In 2012, Ethiopia has a population of 27.19 million
women aged 15 years and older who are at risk of de-
veloping cervical cancer. Current estimates indicate
that every year 7095 women are diagnosed with cervical
cancer and 4732 die from the disease. The disease
ranks 2nd most frequent cancer among women. The
disease has crude incidence rate of 16.3 per 100,000
populations per year in the country. Only 0.6 % women
age 18–69 years was screened every 3 years [9].
As evidences showed HIV infected women are at risk
for CC [10–13]. Cervical cancer is about 7.9 times more
common in HIV infected women than none infected
ones [10]. Cervical squamous intraepithelial lesion was
about 7.04 times higher in HIV positive compared HIV
negative women [12]. Nearly a quarter (22.1 %) of
Southern Ethiopia HIV-Infected Women were positive
for precancerous cervical cancer [13].
Cervical cancer which is caused by persistent infection
with human papillomavirus [1, 7, 12, 14–17] is preventable
disease, yet the number of cases globally is expected to
almost double by the year 2025 [18]. Doing regular screen-
ing (no more than once every three to five years) can pre-
vent the disease by around 45 of the cases in age of 30s
and 75 % cases in 50s and 60s [19, 20]. Screening can be
done using Pap smear [20], human papillomavirus testing
[21] and visual inspection with acetic acid [22].
In the presence of high risk for acquiring cervical can-
cer among HIV patients, awareness and acceptance of
the screening is low. In Boston, of eligible women for
screening about 53.0 % had not undergone screening
[23]. In Kenya teaching and referral hospital the self-
reported screening uptake was 17.5 % [24]. About half
(56.2 %) of HIV positive Nigerian women were aware of
cervical cancer. In same country, only one every ten
(9.4 %) of HIV positive women were screened for cer-
vical cancer [25].
In Addis Ababa, Ethiopian women had very low aware-
ness of cervical cancer and the etiology of cervical cancer
was thought to be due to breaching social taboos or
undertaking unacceptable behaviors. As a result, the per-
ceived benefits of modern treatment were very low [26].
Although cervical cancer is a leading cause of cancer
related morbidity and mortality among women in
Ethiopia, its screening coverage as part of HIV care was
low, only covers less than 1 % due to have no national
screening program [18, 27, 28]. Hence the current study
used to assess the willingness and acceptability of cer-
vical cancer screening and its determinants among HIV
positive women. The obtained information will be used
for decision makers and organizations working on can-
cer and HIV/AIDS to consider and integrate cervical
cancer screening as part of HIV/AIDS diagnosis and
treatment guideline since there is no prior local evidence
up to our knowledge.
Methods and materials
Study design and setting
A cross-sectional study design using both quantitative
and qualitative research method was conducted on HIV
treatment centers in Addis Ababa which is the capital
city of Ethiopia. In the town, there are 45 hospitals, 72
health centers, and 43 health posts owned by ministry of
health [29, 30]. These service sites were providing HIV
diagnosis and treatment and its related supportive ser-
vices. There are about 210,306 people living with HIV/
AIDS in Addis Ababa of which 124,609 are women [31].
All HIV infected women above age of 17 years and
coming for chronic HIV care in public health institutions
of Addis Ababa during study period were the study
populations.
Sample size determination and sampling strategy
The sample size for quantitative part was determined by
a single population proportion formula using 95 % confi-
dence interval (a = 0.05), 5 % margin of error (d) and the
proportion (p) of cervical cancer screening in women




p 1−pð Þð Þ=d2
The final sample size after adding 10 % contingency
was 333.
For qualitative part two women from each referral
hospital and one woman from each health centers was
selected for in-depth interview.
Among Addis Ababa regional health bureau owned
public health institutions, three referral hospitals and
eight health centers providing ART service were selected
for study by lottery method. To calculate the sampling
interval for quantitative study, the HIV patient flow for
the past six consecutive months before data collection
period was taken from each selected health institutions
and added for approximation of future sampling frame.
Selection of participants was done using systematic ran-
dom sampling method based on arrival order of HIV in-
fected women to the health institution for medical care.
The staring participant was selected by lottery method
from sample interval. The interviewed participant’s cor-
responding medical record was reviewed for assessing
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laboratory measurements like CD4 count and clinical
stages of HIV/AIDS.
For qualitative data, purposive sampling method was
used to select women for the in-depth interview in se-
lected health institutions. Women who were not selected
for interview in quantitative study were included for
qualitative part.
Data collection procedure and data quality management
For quantitative study, a structured questionnaire which
was developed by reviewing different literatures was
used for data collection. The questionnaire was trans-
lated in to local language (Amharic) and back translated
to check consistency. The data collection tool was pre-
tested among 16 patients and identified errors were cor-
rected accordingly. The outcome variable of the study
was cervical cancer screening acceptability. For the
qualitative aspect a semi-structured interview guide was
prepared in English and translated to local language of
Amharic version. The in-depth interview was tape re-
corded and note was taken during interview.
To maintain quality of data; standardized and pre-
tasted data collection tools were used for both quantita-
tive and qualitative studies. Appropriate training was
given for data collectors and supervisors. Daily supervi-
sion was carried out by supervisors and principal investi-
gators to check completeness of the questionnaire. The
quantitative data was entered twice by trained data clerk
to check correct data entry. In addition at the end of
data entry data cleaning were done using frequencies,
cross tabulations, sorting and listing to check missed
values and outliers. Errors identified during data collection
were corrected accordingly at the field and those errors
occurred during/after data entry were corrected by re-
vising the original questionnaire.
Operational definitions
– Willingness to be screened for cervical cancer - if a
women willing for testing but not decided to be
screened in the near future [25].
– Acceptance to be screened for cervical cancer- if a
women willing for testing and decided to be
screened in the near future” [25].
– Knowledgeable about cervical cancer- if participant
answers 7 questions out of 13 Knowledge
assessment questions.
Data analysis
For quantitative data, code was given and entered in to
Epi-info version 3.5.1 software and exported in to SPSS
version 20 statistical package for analysis. Multi-co-
linearity was checked using Pearson correlation, tolerance
or variance inflation factor and there were not multi-co-
linearity. Independent Variables associated with outcome
variable with p-value 0.05 or less at bivariate analysis and
not co-linear were entered into multivariate analysis via
binomial logistic regression to get adjusted predictors.
Descriptive statics of continuous variables were pre-
sented using mean, median and discrete variables were
presented using percentage, and tables. P-value <0.05
was used as cut off point of statistical significance for
analytical analysis.
The qualitative in-depth interview was translated to
English version by arranging the points according to for-
warded questions. Then framework analysis method was
employed to grasp the detail information.
Ethical issue
The study proposal was approved by the institutional
review board of Addis Ababa University. Letter from
the Research Ethics Committee was submitted to Addis
Ababa regional health bureau to get permission for
conducting the study. To protect anonymity and confi-
dentiality of the participants, both data collectors and
supervisors were working in ART clinics in addition
personal identifier data was not collected. Informed
written consent was obtained from respondents after
explaining the purpose of the study.
Results
A total of 322 study participants were included with a
response rate of 96.7 % and about 14 in depth interviews
were conducted based on saturation of information.
Characteristics of the study participants
The dominant ethnicity and religion were Amhara
(53.7 %) and orthodox Christianity (71.7 %) respect-
ively. Mean age of the study participants was 35.65
(SD ±10.17). Most of them were educated (78.3 %) and
about half of them were have no regular source of in-
come (51.2 %), had experience of pregnancy 1–2 times
(47.5 %), diagnosed as having HIV before 6–10 Years
ago (49.1 %). Most of (91.9 %) the participants were
initiated ART and were WHO clinical stage 2 (34 %)
HIV patients.
On card review, CD4 count of 211 (65.5 %) partici-
pants were less than or equal to 500 cells/ul, and the
remaining 111(34.5 %) were CD4 count greater than 500
cells/ul. Most of the participants in the qualitative were
attended secondary education, married and were be-
tween the age of 29 and 35.
Cervical cancer awareness, knowledge and test
acceptance
Of the whole participants 110 (34.2 %) know about cer-
vical cancer. And their major sources were health pro-
fessionals during contact on routine HIV chronic care 59
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(53.6 %), media 64 (58.2 %), reading books 13 (11.8 %),
and friends 11(10.0 %) and the least was from family 3
(2.7 %). Regarding knowledge assessment only 81
(25.1 %) was found to be knowledgeable.
Even though they didn’t have detail knowledge regard-
ing the disease, most of the in-depth participants were
aware of cervical cancer. Some of the participants agree
as it is the cancer of the female reproductive tract. Me-
dias are mentioned as a source of knowledge about the
disease for most of the participants and some of them
also experience the disease in their family members and
neighbors.
Majority of participants 97 (88.2 %) believe as the dis-
ease is a preventable. Similarly from the qualitative part,
most of the participants believed as cervical cancer is a
preventable disease. A young respondent mention that
“one can get prevented from cervical cancer by having
the screening test regularly”.
About one third 31.4 % (101) participants knowing the
availability of the screening procedures for the disease
and about one third (62.7 %) were willing to screened
for cervical cancer and a quarter (24.8 %) of them were
decided to screened in the near future.
Most of the participants repudiate to take the screen-
ing test due to assuming, the test is time consuming 43
(35.8 %) (Table 1). The mentioned reasons in in depth
interview were high cost of the test and timing consum-
ing, fear of result of the test (being diagnosed as having
cervical cancer), and a recently HIV diagnosed woman
noted that “the word you have a cancer diagnosis is
really irritating beside my HIV, I think I will get hopeless,
if I am diagnosed as having cervical cancer”.
Only 37 (11.5 %) of the study participants were ever
tested for cervical cancer in their life time. The time of
screening was before HIV/AIDS diagnosis (29.7 %),
within one year of HIV/AIDS diagnosis (32.5 %) and
after one year of HIV/AIDS diagnosis (37.8 %). Of those
who get the screening test, about 11(29.7 %) were posi-
tive for the test.
In multiple logistic regression, after adjustment for
potential cofounders, the factors that enhance accept-
ing of screening were being in age group of 40–49, 50–
59 and >60 years compared <29; having above 12 grade
educational level compared to read and write; having
regular source of income; getting information about cer-
vical cancer from health professionals, having awareness
of the test and needing the screening to take early meas-
ure. Respondents not knowing cervical cancer as prevent-
able were less likely to accept the screening (Table 2).
Discussion
In this study one third (34.2 %) participants knew the
availability of screening test for CC and this finding was
similar with HIV positive women in Lagos, Nigeria
(34.5 %) [25] and it was higher than two studies in
Nigeria (15.5 %) [33], (6.5 %.) [34]. The possible reasons
for discrepancy of the result might be variation in study
populations i.e. all women [33, 34] vs HIV infected
women in current study, regional state or country spe-
cific promotion policy variations, variations in involve-
ment of the CC education in media and its exposure and
differences in socio-cultural condition.
In current study majority of participants mentioned as
health professionals were their main source of informa-
tion for CC and the finding is in agreement with prior
studies [33, 35–37].
The current finding of two third participants (62.7 %)
willing to be screened for cervical cancer were lower than
a study done in Nigeria (96.5 %) [38] and Mozambique
(84 %) [39] and the difference might be attributed by vari-
ations in health policy on promotion of CC, variations on
awareness creation using mass-media and socio-economic
variations.
The current study revealed as one every ten (11.5 %)
participants were ever tested for CC in their life time
and this is in line with a study in rural Mozambique
(11 %) [39], Sokoto, Nigeria, (10 %) [40], two studies in
Kenya (12.3 %) [41] and (17.5 %) [25] and HIV positive
women in Lagos, Nigerian (9.4 %) [25]. The finding was
higher than two studies in Ogun State, Nigeria (4.8 %)
[34] and (9.5) [42] and it was lower than a study among
HIV-positive women Ottawa, Ont (58 %) [23]. The rea-
son of being higher than Ogun State, Nigeria [34, 42]
might be attributed by variations of study populations
i.e. all women in [35] since HIV infected women may
frequently visit health institutions and can get health
professionals which are the main source of information
for screening [33, 35–37].
The current finding of most of the participants not
willing to take the test due to assuming that the test is
time consuming (35.8 %), fear of being positive for the
Table 1 Reason for not having screening test among study




Variable Frequency Percentage (%)
High cost of the test 36 30.0
Religious denial 12 10.0
Partner acceptance 12 10.0




Fear of test result 37 30.8
Lack of female screeners 16 13.3
No reason 25 20.8
Others 9 10.8
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test (30.8 %) and high cost of the test (30.0 %) was in
agreement with the a similar study in HIV positive
women in Lagos, Nigerian [25] and Kenya [41].
In this study, participants having above 12th grade edu-
cational level compared to read and write, and having
awareness about CC were 1.2 and 3.6 times respectively
more likely accepting the screening and the finding was
in parallel with a study among HIV positive women in
Lagos, Nigerian in which having a tertiary education
were enhancing screening by 1.4 times (OR = 1.4; 95 %
CI: 1.03-1.84) and those aware of cervical cancer were
1.5 times (OR: 1.5; 95 % CI: 1.2-2.0) more likely accept-
ing the screening [25].
In current study, participants who were getting infor-
mation about cervical cancer from health professionals
were 6 times more likely accepting the screening and
this finding was supported by prior studies [33, 40].
Conclusion and recommendation
One third (34.2 %) participants knew cervical cancer and
two third (62.7 %) were willing for the test though only
a quarter (24.8 %) were accepted the test. After adjust-
ment in multivariate analysis, the factors that enhance
accepting of screening were being in age group of 40–
49, 50–59 and >60 years compared <29; having above
12th grade educational level compared to read and write;
having regular source of income; getting information
about cervical cancer from health professionals, having
awareness of the test, needing screening to take early
measure and knowing cervical cancer as preventable dis-
ease. Thus organizations working on cancer and HIV/
AIDS should further work to enhance awareness, and
acceptability of the test. Ethiopian ministry of health
should establish CC screening program since two third
participants were willing for screening. Screening re-
fusals as a result of assuming time consuming of the
test, fear of the test result and anticipated high cost need
to be addressed through advocacy and public
mobilization. A further study with a large sample size is
recommended to validate the current finding.
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Table 2 The association of variables with accepting of cervical
cancer screening among study participants, 2014
Variable (AOR, 95 % CI)
Socio-demographic characteristics
Age in completed years
<29 Years 1
30-39 Years 0.96 (0.372, 1.671)
40-49 Years 3.8 (1.212, 12.290)*
50-59 Years 4.2 (1.505, 17.482)*
>60 Years 8.2 (1.104, 61.543)*
Level of education
Read and write 1
Primary Education (1–8) 1.2 (0.417, 3.846)
secondary Education (9–12) 1.6 (0.479, 5.600)
Higher education above 12 1.2 (1.313, 5.269)*
Regular source of income
Yes 3.2 (1.346, 8.005)*
No 1
First most cause of cervical cancer
Viral 1.8 (0.011, 3.895)
I don't know 0.619 (0.001, 2.233)
Others 1
Health professional source
Yes 6.0 (1.440, 83.933)*
No 1
Is cervical cancer preventable
Yes 1
No 0.07 (0.001, 0.249)*
Aware of the test used
Yes 3.6 (1.395, 33.76)*
No 1
Reason of testing to take early measure
Yes 9.9 (1.423, 309.316)*
No 1
High cost of the test
Yes 1.001 (0.811, 29.268)
No 1
WHO Clinical staging
WHO stage 1 1
WHO stage 2 0.68 (0.079, 5.870)
WHO stage 3 0.67 (0.042, 10.675)
WHO stage 4 0.011 (0.463, 3.282)
AOR adjusted odds ratio, WHO world health organization
* = statistically significant
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